Description
A reversible 5-LO inhibitor; inhibits 5-LO activity in RBL-1 cell supernatant (IC50 = 0.5 µM); inhibits LTB4 production induced by A23187 in purified human PMNLs (IC50 = 0.6 µM); prevents antigen challenge-induced increases in specific lung resistance in a sheep model of asthma at 4 to 8 hours post-challenge at 10 mg/kg, p.o., 2 hours pre-challenge
Formal name: N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-urea
Synonyms: A 64077
Molecular weight: 236.3
CAS: 111406-87-2
Purity: >98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Lipoxygenases||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Leukotrienes||Research Area|Immunology & Inflammation|Innate Immunity||Research Area|Immunology & Inflammation|Pulmonary Diseases|Asthma||Research Area|Lipid Biochemistry|Lipoxygenase Pathways